Navigation Links
Lorillard Tobacco Company Comments on Harvard School of Public Health Report

GREENSBORO, N.C., July 16 /PRNewswire/ -- While Lorillard Tobacco Company (a wholly-owned subsidiary of Lorillard, Inc. (NYSE: LO)) has not yet had the opportunity to fully review the latest report from the Harvard School of Public Health, the company is gratified that the report reaffirms its view with respect to the present state of the science examining menthol use in cigarettes, including that:

-- "The available [scientific] evidence remains inconclusive" that menthol cigarettes confer a higher risk than non-mentholated cigarettes for smoking-related diseases.

-- "Recent studies did not find significant differences in risk for disease between menthol and non-menthol smokers."

-- "Research on differences in cessation outcomes between menthol and non-menthol smokers had conflicting results."

However the report's conclusion that Lorillard controls or alters the menthol levels in its products to promote smoking initiation or addiction is categorically false.

Lorillard does not control levels of menthol to promote smoking among adolescents and young adults. Furthermore, Lorillard does not engineer any of its cigarettes to promote smoking initiation or nicotine addiction. Importantly, the target menthol specifications for Newport have not changed at all since 2000.

Lorillard is in the business of manufacturing cigarettes for sale to adult smokers. The company wants every adult smoker who prefers menthol cigarettes to choose its Newport product. This is why Lorillard strives to make a product with superior taste and consistency.

The company also rejects the report's conclusion that Lorillard targets youth smokers. The authors should know that pursuant to an agreement with the state's Attorneys General, Lorillard does not advertise in magazines that have a youth readership of 15 percent or greater and/or a circulation of two million or more readers under 18 years of age. This is not a new policy and has been in effect for years. Contrary to the report's assertion, while the magazine advertising expenditures for Newport may fluctuate from year to year, overall spending on magazine advertising has decreased over the last 10 years.

About Lorillard, Inc.

Lorillard, Inc. (NYSE: LO), the parent company of Lorillard Tobacco Company, is the third largest manufacturer of cigarettes in the United States. Lorillard was founded in 1760, and is the oldest continuously operating tobacco company in the U.S. Newport(R), Lorillard's flagship brand, is a menthol-flavored premium cigarette brand and the top selling menthol and second largest selling cigarette in the U.S. In addition to Newport, the

Lorillard product line has five additional brand families marketed under the Kent(R), True(R), Maverick(R), Old Gold(R) and Max(R) brand names. These six brands include 44 different product offerings which vary in price, taste, flavor, length and packaging. Lorillard's manufactures all of its products at its Greensboro, North Carolina facility and maintains its headquarters there.

Forward-Looking Statements

Certain statements made in this press release are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, or the Reform Act. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements, and may contain the words "expect", "intend", "plan", "anticipate", "estimate", "believe", "will be", "will continue", "will likely result", and similar expressions. In addition, any statement that may be provided by management concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible actions by Lorillard, Inc. are also forward-looking statements as defined by the Reform Act.

Forward-looking statements are based on current expectations and projections about future events and are inherently subject to a variety of risks and uncertainties, many of which are beyond the control of Lorillard, Inc., that could cause actual results to differ materially from those anticipated or projected. Information describing factors that could cause actual results to differ materially from those in forward-looking statements is available in Lorillard, Inc.'s filings with the Securities and Exchange Commission. These filings are available from the SEC over the Internet or in hard copy, and are, in some cases, available from Lorillard, Inc. as well. Forward-looking statements speak only as of the time they are made, and Lorillard, Inc. expressly disclaims any obligation or undertaking to update these statements to reflect any change in expectations or beliefs or any change in events, conditions or circumstances on which any forward-looking statement is based.


Michael W. Robinson


SOURCE Lorillard Tobacco Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from Lorillard Tobacco on FDA-Tobacco Regulation Legislation
2. FTC Acts to Prevent Tobacco Industry Deception About Tar, Nicotine Levels; Congress Should Go Further by Giving FDA Authority Over Tobacco Products
3. Smokeless Tobacco Products Do Raise Cancer Risk
4. Grandmother is Inspiration for Winner of Tobacco Free Florida YouCare Contest
5. Rivalry Aside, Marlins and Rays Team Up To Fight Tobacco
6. Major Associations Band Together to Urge Congressional Action on Tobacco Legislation
7. Smokeless Tobacco: Not a Harmless Substitute
8. World No Tobacco Day Sounds Urgent Call for Nations to Fight Tobacco Use, Save Lives
9. PA State Health Officials Encourage Smokers to Quit on World No Tobacco Day
10. A new way to look at lung cancer and tobacco carcinogens
11. World No Tobacco Day: Global Organizations Join Forces To Break the Tobacco Marketing Net and Help Children Grow Up Smoke-Free
Post Your Comments:
(Date:11/24/2015)... ... ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located in ... staff members at their recovery center. The videos highlight some of the various aspects ... things that make their recovery program so unique. , “Making the decision to seek ...
(Date:11/24/2015)... ... November 24, 2015 , ... Cold Shoulder , LLC launched their Pro Vest, the latest ... hit their goal of $20,000 in under 10 hours. , The campaign, ... PRO Weight Loss Vest to the market. , The PRO Vest provides consumers with a ...
(Date:11/24/2015)... ... ... Dr. Rodney E. Willey , has answered a new calling – to relieve snoring ... treatment for snoring and sleep apnea through oral appliance therapy. He is ... in the US, one of four in the Illinois area. , Dr. Willey’s ...
(Date:11/24/2015)... ... ... Bibliomotion is thrilled to announce the launch of UNCONVENTIONAL ... Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health System (November ... of patients and their families, shaped my desire to improve the system of care. ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... products, announces Innovative Blending, a household invention that revolutionizes the vending machine industry ... Smoothie Bars market is worth $2 billion," says Scott Cooper, CEO and Creative ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... DELHI , November 25, 2015 ... invoked due to repeated failure of IVF cycles. After ... Bhatia was totally dejected and had lost all hopes that she would be ... first Indian miracle child conceived after failure of over ... to abroad (UK) before they decided to take one last attempt ...
(Date:11/24/2015)...  In the pharmaceutical industry, companies want to rapidly ... uncover new insights, tactics and strategies that will improve ... --> However, organizations often find it is difficult ... that all rules and regulations are met to ensure ... to efficiently launching market research projects is the conflicting ...
(Date:11/24/2015)... , November 24, 2015 --> ... report "Spine Biologics Market by Product Type (Bone Graft, Bine ... Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and ... global market was valued at $1.90 Billion in 2014 and ... CAGR of 4.4% during the forecast period of 2015 to ...
Breaking Medicine Technology: